Publication | Closed Access

Gut microbiome and tissue metabolomics reveal the compatibility effects of Xiaoyaosan on depression based on “gut-liver-kidney” axis

DysbiosisPsychiatryTissue MetabolomicsMedicinePhysiologyMetabolomic ProfilingDepressionGut-organ AxisDepression PathogenesisIntestinal MicrobiotaMicrobiomeMetabolismPharmacologyMetabolomicsCompatibility EffectsGut Microbiome